Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)
NCT06837181 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2026-02-10
Summary
This multicenter cross-sectional study will include a diverse population of adolescents and adults with CF.
The overall Aim is to describe prevalence of diabetes microvascular complications and macrovascular surrogates in people with established CFRD.
Conditions
- Cystic Fibrosis (CF)
- Cystic Fibrosis-related Diabetes
- Diabetes
- Retinopathy
- Neuropathy
- Nephropathy
- Blood Pressure
- Cardiovascular Risk
- Microvascular
Interventions
- OTHER
-
observational study
This is an observational study.
Sponsors & Collaborators
-
Cystic Fibrosis Foundation
collaborator OTHER -
Jaeb Center for Health Research
lead OTHER
Eligibility
- Min Age
- 12 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-09-18
- Primary Completion
- 2028-11-30
- Completion
- 2028-11-30
Countries
- United States
Study Locations
More Related Trials
-
Clinical Outcomes of Triple Combination Therapy in Severe Cystic Fibrosis Disease.
NCT04038710 ·Status: COMPLETED
-
Early Intervention in Cystic Fibrosis Exacerbation
NCT01104402 ·Status: COMPLETED ·Phase: NA
-
Early Intervention in Pulmonary Exacerbation in Cystic Fibrosis
NCT00850551 ·Status: COMPLETED ·Phase: NA
-
Pilot Study Testing the Effect of Ivacaftor on Lung Function in Subjects With Cystic Fibrosis and Residual CFTR Function
NCT01685801 ·Status: COMPLETED ·Phase: PHASE2
-
Simplification of CF-related Diabetes Screening at Home
NCT03227094 ·Status: COMPLETED ·Phase: NA
-
Nutritional, Metabolic and Respiratory Status in Cystic Fibrosis
NCT00476281 ·Status: COMPLETED ·Phase: NA
-
Strength and Muscle Related Outcomes for Nutrition and Lung Function in CF
NCT05639556 ·Status: ACTIVE_NOT_RECRUITING
-
A Phase 2 Study to Evaluate Efficacy and Safety of VX-561 in Subjects Aged 18 Years and Older With Cystic Fibrosis
NCT03911713 ·Status: COMPLETED ·Phase: PHASE2
-
Glucose Metabolism in Cystic Fibrosis Related Diabetes (CFRD)
NCT07102043 ·Status: NOT_YET_RECRUITING
-
Genetic Modifiers of Cystic Fibrosis Related Diabetes
NCT01113216 ·Status: ENROLLING_BY_INVITATION
-
A Study to Evaluate Efficacy of Ivacaftor in Subjects With Cystic Fibrosis Who Have a 3849 + 10KB C→T or D1152H CFTR Mutation
NCT03068312 ·Status: COMPLETED ·Phase: PHASE3
-
CHaractErizing CFTR Modulated Changes in Sweat Chloride and Their Association With Clinical Outcomes
NCT03350828 ·Status: ACTIVE_NOT_RECRUITING
-
6 Minute Walk Test in Cystic Fibrosis
NCT02538575 ·Status: COMPLETED ·Phase: NA
-
A Study to Determine the Variability of a 6-Minute Walk Test in Cystic Fibrosis Subjects With Advanced Lung Disease
NCT00311506 ·Status: COMPLETED
-
Observational Trial of the Longitudinal Effects of CFTR Modulator Drugs
NCT04353752 ·Status: COMPLETED
-
Comparing Chest Images From MRI to CT in Patients With Cystic Fibrosis (CF)
NCT01860872 ·Status: COMPLETED
-
Tracking CF Lung Disease Through the Early Years: Utility of the LCI
NCT03138772 ·Status: COMPLETED
-
PREDICT Trial: PRospective Evaluation of NTM Disease In CysTic Fibrosis
NCT02073409 ·Status: ENROLLING_BY_INVITATION
-
Evaluation of Sit-to-stand Test in Patients With Cystic Fibrosis and Matched Controls.
NCT03524859 ·Status: COMPLETED
-
Evaluation of Salt Status in Patients With Cystic Fibrosis
NCT04556162 ·Status: COMPLETED
-
A Pilot Study to Evaluate the Use of Smart Adherence Technology to Measure Lumacaftor/Ivacaftor Adherence in CF Subjects Homozygous for the F508del CFTR Mutation
NCT02823470 ·Status: TERMINATED ·Phase: PHASE4
-
Evaluating the Impact of Chronic Rhinosinusitis on the Health-Related Quality of Life Among Adults With Cystic Fibrosis
NCT02003079 ·Status: COMPLETED
-
Airway Clearance Therapy on Hyperpolarized 129Xenon and MRI
NCT03593434 ·Status: COMPLETED
-
Remotely Supervised Exercise for Adults With Cystic Fibrosis
NCT05173194 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate Efficacy and Safety of Ivacaftor in Subjects With Cystic Fibrosis Aged 3 Through 5 Years Who Have a Specified CFTR Gating Mutation
NCT02742519 ·Status: TERMINATED ·Phase: PHASE3